[go: up one dir, main page]

DK1224177T3 - Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner - Google Patents

Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner

Info

Publication number
DK1224177T3
DK1224177T3 DK00970988T DK00970988T DK1224177T3 DK 1224177 T3 DK1224177 T3 DK 1224177T3 DK 00970988 T DK00970988 T DK 00970988T DK 00970988 T DK00970988 T DK 00970988T DK 1224177 T3 DK1224177 T3 DK 1224177T3
Authority
DK
Denmark
Prior art keywords
preparation
oxazolines
tetrahydrofurans
disclosed
nelfinavir
Prior art date
Application number
DK00970988T
Other languages
Danish (da)
English (en)
Inventor
Juliette Kharsa Busse
Scott Edward Zook
Bennett Chaplin Borer
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Application granted granted Critical
Publication of DK1224177T3 publication Critical patent/DK1224177T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
DK00970988T 1999-10-21 2000-10-19 Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner DK1224177T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16069599P 1999-10-21 1999-10-21
PCT/US2000/028815 WO2001029013A1 (en) 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans

Publications (1)

Publication Number Publication Date
DK1224177T3 true DK1224177T3 (da) 2004-05-03

Family

ID=22578030

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00970988T DK1224177T3 (da) 1999-10-21 2000-10-19 Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner

Country Status (20)

Country Link
US (3) US6403799B1 (hu)
EP (1) EP1224177B1 (hu)
JP (2) JP2003512361A (hu)
KR (1) KR100706938B1 (hu)
CN (3) CN1266140C (hu)
AT (1) ATE259360T1 (hu)
AU (1) AU775783B2 (hu)
BR (1) BR0015229A (hu)
CA (1) CA2387997C (hu)
CZ (1) CZ20021361A3 (hu)
DE (1) DE60008270T2 (hu)
DK (1) DK1224177T3 (hu)
ES (1) ES2215737T3 (hu)
HU (1) HUP0203214A3 (hu)
IL (1) IL149197A0 (hu)
PL (1) PL364878A1 (hu)
PT (1) PT1224177E (hu)
RU (1) RU2242468C2 (hu)
SI (1) SI1224177T1 (hu)
WO (1) WO2001029013A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2872491T3 (pl) 2012-07-11 2021-12-13 Blueprint Medicines Corporation Inhibitory receptora czynnika wzrostu fibroblastów
RU2704112C2 (ru) 2013-10-25 2019-10-24 Блюпринт Медсинс Корпорейшн Ингибиторы рецептора фактора роста фибробластов
US9695165B2 (en) 2014-01-15 2017-07-04 Blueprint Medicines Corporation Inhibitors of the fibroblast growth factor receptor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
CA2153777A1 (en) 1993-01-15 1994-07-21 Siegfried H. Reich Hiv protease inhibitors
EP0686157A1 (en) 1993-02-26 1995-12-13 Schering Corporation 2-benzyl-polycyclic guanine derivatives and process for preparing them
US5527829A (en) 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
ATE416158T1 (de) 1995-09-26 2008-12-15 Japan Tobacco Inc Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen
ES2233976T3 (es) 1995-09-26 2005-06-16 Japan Tobacco Inc. Procedimiento para producir derivados amidicos e intermedios.
US5962725A (en) * 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US5925759A (en) * 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
AU8029000A (en) 2001-04-30
AU775783B2 (en) 2004-08-12
US20020038033A1 (en) 2002-03-28
IL149197A0 (en) 2002-11-10
WO2001029013A1 (en) 2001-04-26
ES2215737T3 (es) 2004-10-16
CN1390210A (zh) 2003-01-08
EP1224177B1 (en) 2004-02-11
SI1224177T1 (en) 2004-06-30
CA2387997C (en) 2006-06-13
ATE259360T1 (de) 2004-02-15
HUP0203214A3 (en) 2005-01-28
US20030023092A1 (en) 2003-01-30
DE60008270T2 (de) 2004-07-15
HUP0203214A2 (hu) 2003-01-28
DE60008270D1 (de) 2004-03-18
CN1539832A (zh) 2004-10-27
US6403799B1 (en) 2002-06-11
EP1224177A1 (en) 2002-07-24
PL364878A1 (en) 2004-12-27
BR0015229A (pt) 2002-07-23
JP2003512361A (ja) 2003-04-02
JP2008007522A (ja) 2008-01-17
CN1266140C (zh) 2006-07-26
HK1051365A1 (en) 2003-08-01
KR20020047255A (ko) 2002-06-21
HK1068880A1 (en) 2005-05-06
CZ20021361A3 (cs) 2003-03-12
RU2242468C2 (ru) 2004-12-20
CN1162408C (zh) 2004-08-18
PT1224177E (pt) 2004-06-30
KR100706938B1 (ko) 2007-04-11
US6472534B2 (en) 2002-10-29
CA2387997A1 (en) 2001-04-26
CN1539834A (zh) 2004-10-27

Similar Documents

Publication Publication Date Title
DK1353917T3 (da) Ny fremgangsmåde til syntesen af 5-(4-fluorphenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrol-3-carboxylsyre phenylamid
PL358887A1 (en) Process for the preparation of substituted octanoyl amides
DK0835257T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af camptothecin-derivater (CPT-11) og beslægtede forbindelser
EA200601672A1 (ru) Конъюгаты гидроксиалкилкрахмала и белка, полученные восстановительным аминированием
DE60041584D1 (de) Substituierte oxoazaheterozyclische verbindungen
PL372799A1 (en) New compounds
ATE326454T1 (de) Neue bernsteinsäure derivative als cysteine- protease-inhibitoren
DK1180544T3 (da) Fremgangsmåde til fremstilling af syntesegas
ATE252097T1 (de) N-heterocyclische derivate als nos inhibitoren
DE60218703D1 (de) (-)-1-(3,4-dichlorphenyl)-3-azabicyclo ä3.1.0ühexan, zusammensetzungen davon und verwendung als dopamin-wiederaufnahme-hemmer
EA200400491A1 (ru) Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции
NO20024808D0 (no) Fremgangsmåte ved syntesen av perindopril og farmasöytisk akseptable salter derav
EP1421055A4 (en) PROCESS FOR SYNTHESIS OF AMINES SUCH AS EPHEDRINE AND INTERMEDIATE PRODUCTS
NO984344L (no) Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger
Macdonald et al. A flexible, practical, and stereoselective synthesis of enantiomerically pure trans-5-oxohexahydropyrrolo [3, 2-b] pyrroles (pyrrolidine-trans-lactams), a new class of serine protease inhibitors, using acyliminium methodology
DK1224177T3 (da) Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner
DK1246813T3 (da) Fremgangsmåde til fremstilling af Citalopram
DK1778710T3 (da) Tanaprogetderivater, -metabolitter og anvendelser deraf
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
DK1102765T3 (da) Fremgangsmåde til syntese af (1H)-benzo[c]quinolizin-3-on-derivater
DK1089976T3 (da) Fremgangsmåde til fremstilling af 5-bromisoquinolin og dets 8-nitroderivat
NO20041573L (no) Aralkyl-tetrahydro-pyridiner, deres fremstilling og farmasoytiske preparater inneholdende de samme
YU30202A (sh) Postupak za dobijanje oksazolina iz tetrahidrofurana
DK0708762T3 (da) Fremgangsmåde til fremstilling af HIV protease-inhibitorer
NO20024503L (no) FremgangsmÕte for tilveiebringelse av startkulturer med en konsistent kvalitet